Challenge and Therapeutic Studies Using Alpha-Methyl-para-Tyrosine (AMPT) in Neuropsychiatric Disorders: A Review

E-ISSN： 1875-6166|8|4|249-256

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.8, Iss.4, 2008-12, pp. : 249-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Role of Zonisamide in Neuropsychiatric Disorders

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 968-975

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1831-1839

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders

By Marenco Stefano Weinberger Daniel R.

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 173-185

Adis International

Access to resources Recommend Favorite

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite